Fresenius Medcl patent expiration

1. Phoslo patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6576665 FRESENIUS MEDCL Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
Apr, 2021

(3 years ago)




Drugs and Companies using CALCIUM ACETATE ingredient

Market Authorisation Date: 02 April, 2001

Treatment: NA

Dosage: CAPSULE

How can I launch a generic of PHOSLO before it's drug patent expiration?
More Information on Dosage

PHOSLO family patents

Family Patents

2. Phoslo Gelcaps patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6576665 FRESENIUS MEDCL Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
Apr, 2021

(3 years ago)

US6875445 FRESENIUS MEDCL Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
Jul, 2021

(3 years ago)




Drugs and Companies using CALCIUM ACETATE ingredient

Market Authorisation Date: 02 April, 2001

Treatment: NA

Dosage: CAPSULE

How can I launch a generic of PHOSLO GELCAPS before it's drug patent expiration?
More Information on Dosage

PHOSLO GELCAPS family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Phoslyra patent expiration

PHOSLYRA IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8592480 FRESENIUS MEDCL Liquid compositions of calcium acetate
Jul, 2027

(2 years from now)

US9089528 FRESENIUS MEDCL Liquid compositions of calcium acetate
Jul, 2027

(2 years from now)

US8591938 FRESENIUS MEDCL Liquid compositions of calcium acetate
Feb, 2030

(5 years from now)




Drugs and Companies using CALCIUM ACETATE ingredient

Market Authorisation Date: 18 April, 2011

Treatment: Use of phoslyra for reduction of serum phosphorous in patients

Dosage: SOLUTION

How can I launch a generic of PHOSLYRA before it's drug patent expiration?
More Information on Dosage

PHOSLYRA family patents

Family Patents